PTTG1IP and thyroid gland carcinoma: More recently, Smith and co-workers [20] have, however, suggested that radioiodide uptake in thyroid cancer cells could be increased and, thus, efficacy of the treatment could be improved by targeting PTTG1IP expression via the modulation of phosphorylation.